According to this report，from the perspective of the international pharmaceutical market，the situation facing the “14th Five-Year Plan” is that the global pharmaceutical market is growing steadily；the value of the API industry chain is increasing；the global trade protectionism is heating up；and the number of new drugs at the R&D stage is increasing rapidly. From the perspective of the domestic pharmaceutical market，the domestic structure of drug usage will be adjusted rapidly；generic drugs will still be the mainstream of clinical drugs；the use of innovative drugs and biological drugs will increase；innovative companies are at a critical stage of development；more domestic innovative drugs will apply to get access during the “14th Five-Year Plan” period；the industrial structure will be reshaped；volume-based procurement will promote the rapid development of enterprises；and the production of API will be specialized and centralized. The tasks facing the “14th Five-Year Plan” is to promote the transformation of the industry to innovation-driven development，to strengthen the capability building to guarantee the drug supply，to promote enterprise restructuring and integration，to consolidate the foundation of the API industry，to improve the advanced pharmaceutical manufacturing level，and to implement the internationalization strategy of preparations.